Dr. Harshdeep Singh Babbar, MD

Dr. Babbar practices at HonorHealth Scottsdale Thompson Peak Medical Center in Scottsdale, Arizona, part of HonorHealth.

Dr. Babbar's NPI, 1447573191, was assigned on March 9, 2010. Dr. Babbar holds New Mexico license RS2020-0453.

Dr. Babbar's primary practice is HonorHealth Scottsdale Thompson Peak Medical Center, at 7400 East Thompson Peak Parkway, Scottsdale, AZ 85255 in Maricopa County. The practice phone is (480) 324-7001.

Dr. Babbar's primary practice is HonorHealth Scottsdale Thompson Peak Medical Center in Scottsdale, Arizona, part of HonorHealth. Dr. Babbar is also affiliated with HonorHealth Scottsdale Shea Medical Center. The medical group on file is Pioneer Hospitalists. Dmand AI also links Dr. Babbar to 2 more hospitals, 3 medical groups, 2 home health agencies and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Babbar practices, 7 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Babbar's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dmand AI has Dr. Babbar's licenses on file in 2 states: New Mexico and Arizona.

CMS data shows 1,472 Medicare services from Dr. Babbar across 10 procedure codes in 2024, for 248 Medicare patients. Medicare paid $136,467 for them.

CMS counts 248 Medicare patients who saw Dr. Babbar in 2024. The largest group is 75 to 84, with 100 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 18% are also on Medicaid. Their average risk score is 2.81, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Babbar's median patient age at 69, with 43% women.

In 2024, Dr. Babbar wrote 949 Medicare Part D claims for 251 patients. 89% of them were for generic drugs. CMS names the drug for 796 of them, across 21 drugs with 11 or more claims each, at $191,112 in total drug cost. In 2023, CMS named 342 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Babbar for performance year 2024, reported as part of a group. Dr. Babbar accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Babbar as offering telehealth.

CMS Open Payments shows 49 general payments to Dr. Babbar from 11 drug and device companies from 2023 to 2025. Food and beverage make up the largest share, 100% of the total. Merck Sharp & Dohme Corporation paid the most, $271.